Primary radiofrequency ablation of ventricular tachycardia early after myocardial infarction evaluation in an ovine model

Circulation: Arrhythmia and Electrophysiology

Volumn 6, Issue 6, 2013, Pages 1215-1221

  Hsieh, Calvin H C ^a   Chia, Ee May ^a   Huang, Kaimin ^a   Lu, Juntang ^a   Barry, Michael ^a   Pouliopoulos, Jim ^a   Ross, David L ^a   Thomas, Stuart P ^a   Kovoor, Pramesh ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Catheter ablation; Myocardial infarction

Indexed keywords

ABLATION CATHETER; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; ENDOCARDIUM; EVALUATION STUDY; HEART INFARCTION; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RIGHT BUNDLE BRANCH BLOCK; HEART VENTRICLE TACHYCARDIA; HYPOTENSION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; NONHUMAN; PERICARDIAL EFFUSION; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION;

EID: 84892171722     PISSN: 19413149     EISSN: 19413084     Source Type: Journal    
DOI: 10.1161/CIRCEP.113.000447     Document Type: Article

References (30)

1. Solomon SD, Zelenkofske S, McMurray JJ, Finn PV, Velazquez E, Ertl G, Harsanyi A, Rouleau JL, Maggioni A, Kober L, White H, Van de Werf F, Pieper K, Califf RM, Pfeffer MA; Valsartan in Acute Myocardial Infarction Trial (VALIANT) Investigators. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med. 2005;352:2581-2588.
2. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med. 1996;335:1933-1940.
3. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML; Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877-883.
4. Stevenson WG, Wilber DJ, Natale A, Jackman WM, Marchlinski FE, Talbert T, Gonzalez MD, Worley SJ, Daoud EG, Hwang C, Schuger C, Bump TE, Jazayeri M, Tomassoni GF, Kopelman HA, Soejima K, Nakagawa H; Multicenter Thermocool VT Ablation Trial Investigators. Irrigated radiofrequency catheter ablation guided by electroanatomic mapping for recurrent ventricular tachycardia after myocardial infarction: The multicenter thermocool ventricular tachycardia ablation trial. Circulation. 2008;118:2773-2782.
5. Reddy VY, Reynolds MR, Neuzil P, Richardson AW, Taborsky M, Jongnarangsin K, Kralovec S, Sediva L, Ruskin JN, Josephson ME. Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med. 2007;357:2657-2665.
6. Kuck KH, Schaumann A, Eckardt L, Willems S, Ventura R, Delacrétaz E, Pitschner HF, Kautzner J, Schumacher B, Hansen PS; VTACH Study Group. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): A multicentre randomised controlled trial. Lancet. 2010;375:31-40.
7. Sivagangabalan G, Pouliopoulos J, Huang K, Barry MA, Lu J, Thomas SP, Ross DL, Thiagalingam A, Kovoor P. Simultaneous biventricular noncontact mapping and ablation of septal ventricular tachycardia in a chronic ovine infarct model. Circ Arrhythm Electrophysiol. 2009;2:441-449.
8. Hsieh CHC, Chia E-M, Huang K, Lu J, Barry M, Pouliopoulos J, Ross DL, Thomas SP, Kovoor P. Evolution of ventricular tachycardia and its electrophysiological substrate early after myocardial infarction: An ovine model. Circ Arrhythm Electrophysiol. 2013;6:1010-1017.
9. Voss F, Steen H, Bauer A, Giannitsis E, Katus HA, Becker R. Determination of myocardial infarct size by noncontact mapping. Heart Rhythm. 2008;5:308-314.
10. Jacobson JT, Afonso VX, Eisenman G, Schultz JR, Lazar S, Michele JJ, Josephson ME, Callans DJ. Characterization of the infarct substrate and ventricular tachycardia circuits with noncontact unipolar mapping in a porcine model of myocardial infarction. Heart Rhythm. 2006;3:189-197.
11. Haqqani HM, Kalman JM, Roberts-Thomson KC, Balasubramaniam RN, Rosso R, Snowdon RL, Sparks PB, Vohra JK, Morton JB. Fundamental differences in electrophysiologic and electroanatomic substrate between ischemic cardiomyopathy patients with and without clinical ventricular tachycardia. J Am Coll Cardiol. 2009;54:166-173.
12. Cassidy DM, Vassallo JA, Miller JM, Poll DS, Buxton AE, Marchlinski FE, Josephson ME. Endocardial catheter mapping in patients in sinus rhythm: Relationship to underlying heart disease and ventricular arrhythmias. Circulation. 1986;73:645-652.
13. Bogun F, Good E, Reich S, Elmouchi D, Igic P, Lemola K, Tschopp D, Jongnarangsin K, Oral H, Chugh A, Pelosi F, Morady F. Isolated potentials during sinus rhythm and pace-mapping within scars as guides for ablation of post-infarction ventricular tachycardia. J Am Coll Cardiol. 2006;47:2013-2019.
14. Kumar S, Sivagangabalan G, Choi MC, Eipper V, Thiagalingam A, Kovoor P. Long-term outcomes of inducible very fast ventricular tachycardia (cycle length 200-250 ms) in patients with ischemic cardiomyopathy. J Cardiovasc Electrophysiol. 2010;21:262-269.
15. Verma A, Marrouche NF, Schweikert RA, Saliba W, Wazni O, Cummings J, Abdul-Karim A, Bhargava M, Burkhardt JD, Kilicaslan F, Martin DO, Natale A. Relationship between successful ablation sites and the scar border zone defined by substrate mapping for ventricular tachycardia postmyocardial infarction. J Cardiovasc Electrophysiol. 2005;16:465-471.
16. Marchlinski FE, Callans DJ, Gottlieb CD, Zado E. Linear ablation lesions for control of unmappable ventricular tachycardia in patients with ischemic and nonischemic cardiomyopathy. Circulation. 2000;101:1288-1296.
17. Tanner H, Hindricks G, Volkmer M, Furniss S, Kühlkamp V, Lacroix D, DE Chillou C, Almendral J, Caponi D, Kuck KH, Kottkamp H. Catheter ablation of recurrent scar-related ventricular tachycardia using electroanatomical mapping and irrigated ablation technology: Results of the prospective multicenter Euro-VT-study. J Cardiovasc Electrophysiol. 2010;21:47-53.
18. Nair M, Yaduvanshi A, Kataria V, Kumar M. Radiofrequency catheter ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy using non-contact electroanatomical mapping: Single-center experience with follow-up up to median of 30 months. J Interv Card Electrophysiol. 2011;31:141-147.
19. Pratola C, Baldo E, Toselli T, Notarstefano P, Artale P, Paolo A, Ferrari R. Contact versus noncontact mapping for ablation of ventricular tachycardia in patients with previous myocardial infarction. Pacing Clin Electrophysiol. 2009;32:842-850.
20. Buxton AE, Lee KL, DiCarlo L, Gold MR, Greer GS, Prystowsky EN, O'Toole MF, Tang A, Fisher JD, Coromilas J, Talajic M, Hafley G. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med. 2000;342:1937-1945.
21. Richards DA, Byth K, Ross DL, Uther JB. What is the best predictor of spontaneous ventricular tachycardia and sudden death after myocardial infarction? Circulation. 1991;83:756-763.
22. Kumar S, Sivagangabalan G, Zaman S, West EB, Narayan A, Thiagalingam A, Kovoor P. Electrophysiology-guided defibrillator implantation early after ST-elevation myocardial infarction. Heart Rhythm. 2010;7:1589-1597.
23. Zaman S, Sivagangabalan G, Narayan A, Thiagalingam A, Ross DL, Kovoor P. Outcomes of early risk stratification and targeted implantable cardioverter-defibrillator implantation after ST-elevation myocardial infarction treated with primary percutaneous coronary intervention. Circulation. 2009;120:194-200.
24. Stevenson WG, Soejima K. Catheter ablation for ventricular tachycardia. Circulation. 2007;115:2750-2760.
25. Bogun F, Bender B, Li YG, Groenefeld G, Hohnloser SH, Pelosi F, Knight B, Strickberger SA, Morady F. Analysis during sinus rhythm of critical sites in reentry circuits of postinfarction ventricular tachycardia. J Interv Card Electrophysiol. 2002;7:95-103.
26. Irvine J, Dorian P, Baker B, O'Brien BJ, Roberts R, Gent M, Newman D, Connolly SJ. Quality of life in the Canadian Implantable Defibrillator Study (CIDS). Am Heart J. 2002;144:282-289.
27. Hohnloser SH, Kuck KH, Dorian P, Roberts RS, Hampton JR, Hatala R, Fain E, Gent M, Connolly SJ; DINAMIT Investigators. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med. 2004;351:2481-2488.
28. Sweeney MO. The contradiction of appropriate shocks in primary prevention ICDs: Increasing and decreasing the risk of death. Circulation. 2010;122:2638-2641.
29. Mallidi J, Nadkarni GN, Berger RD, Calkins H, Nazarian S. Meta-analysis of catheter ablation as an adjunct to medical therapy for treatment of ventricular tachycardia in patients with structural heart disease. Heart Rhythm. 2011;8:503-510.
30. Zaman S, Kumar S, Narayan A, Sivagangabalan G, Thiagalingam A, Ross DL, Thomas SP, Kovoor P. Induction of ventricular tachycardia with the fourth extrastimulus and its relationship to risk of arrhythmic events in patients with post-myocardial infarct left ventricular dysfunction. Europace. 2012;14:1771-1777.